Venrock Healthcare Capital Partners — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Maze Therapeuticsmazetx.comin𝕏NASDAQ: MAZESep 2025
Maze Therapeutics develops precision medicines for common diseases with high unmet need, using its Compass platform based on human genetics and variant functionalization.
AI & Machine LearningBiotechSouth San Francisco, US
Jason Coloma(Chief Executive Officer)in
Co-investorsAndreessen HorowitzARCH Venture PartnersForesite CapitalFrazier Life SciencesGV (Google Ventures)Janus Henderson Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.